Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
26 Cards in this Set
- Front
- Back
- 3rd side (hint)
What is the pathophysiology of PD?
|
loss of dopamine in the nigrostriatal pathway that causes the thalamus to become overstimulated with GABA
|
|
|
What is the first line drug choice in PD?
|
levodopa (metabolic precursor of dopamine) - can cross the BBB to get in basal ganglia and be converted to dopamine; extremely short half-life (plasma levels drop and cause on-off phenomenon, person gets sudden tremors, etc)
|
|
|
What is the disadvantage of levodopa and how is it remedied?
|
large doses are required because the drug gets decarboxylated in the periphery to dopamine; remedy situation by using carbidopa (blocks GI and peripheral tissue metabolism of DOPA to dopamine- doesn't get by BBB- doesn't hurt the dopamine in the CNS)
|
|
|
What receptor and pathway are most involved in Parkinson's?
|
D2; D2 activation inhibits the indirect pathway (causes more GABA to be released from the striatum leading to more GABA release at the thalamus (causing a net inhibition at the thalamus)
|
|
|
How many dopamine receptors are there and what do they each do to cAMP?
|
D1,2,3,4,5; D1 and D5 cause in increase in cAMP; D2,3,4 cause a decrease in cAMP
|
|
|
What Dopamine receptor do the anti-Parkinson's dopamine agonists largely activate?
|
D2
|
|
|
Name the four dopamine agonist used in parkinson's treatment
|
bromocriptine -ergoline-D2; also used for hyperprolactinemia), ropinirole (non-ergoline-D2), pramipexole (non-ergoline-D3),pergolide (ergoline D2,D1) (hint: old parkinson's pts BuRPP)
|
|
|
Name the benefits and limitations to dopamine agonists.
|
BENEFITS:directly stimulates the dopa receptor, independent of viable dopamine cells, reduces risk of dyskinesia, not affected by dietary proteins(like levadopa), delays motor complications; LIMITS:have to titrate individual dose, s/e:N/dizzy, halluncinations, illusions, somnolence, edema, compulsions
|
|
|
Using what drug with l-dopa (levadopa) will prevent what?
|
carbidopa + L-dopa will prevent the levadopa from being broken down in the periphery by dopa decarboxylase (carbidopa is an inhibitor of dopa decarboxylase)
|
|
|
What two enzymes can metabolize levadopa into dopamine in the periphery?
|
COMT and DDC (dopa decarboxylase)
|
|
|
What is the role of MAOb?
|
break-down dopamine in the presynaptic channel
|
|
|
what is the role of COMT?
|
break-down dopamine in the periphery
|
|
|
Name all the major categories of drugs that can treat Parkinsons.
|
precursor of dopamine(levadopa); dopamine agonists (4), MAOb inhibitors, COMT inhibitors, anti-viral(amantadine), antimuscarinics (BTB), apomorphine
|
|
|
Name the 3 anti-muscarinic drugs used in PD treatment.
|
BTB - benztropine, trihexyphenidyl, biperiden (decrease in dopamine causes an increase in Ach)
|
|
|
Name the COMT inhibitors used in treating parkinson's disease.
|
entacapone and tolcapone (hepatotoxic) - think of al capone
|
None
|
|
Name the MAOb inhibitors.
|
selegiline(metabolized to weak amphetamine) and rasagiline(irreversible blocking)
|
|
|
What would you need to give with apomorphine to prevent a common side-effect?
|
anti-emetic - acute emesis 5-HT3 antagonist like Tigan
|
|
|
Name the anti-PD drug that is a combo levadopa/carbidopa that is orally dissolvable.
|
parcopa
|
|
|
what is an essential tremor?
|
a neurological disorder characterized by shaking of (usually) the hands, evoked by intential movements; very common; incidence and prevalence increases with age; 95% upper limbs, 34% head, benign condition
|
|
|
how do you treat essential tremor?
|
pharm - non-selective b-blocker, propanolol and/or anticonvulsant primidone; SURGICAL: DBS(deep brain stimulation), Thalamotomy, gamma knife thalamotomy.
|
|
|
Name the disorder that is characterized by leg dysthesias that are exacerbated by inactivity, relieved by movement?
|
RLS Restless Leg Syndrome
|
|
|
Name the disorder that is characterized by brief, repetitive jerking of lower limbs while in stage 1 and 2 sleep; causes awakening.
|
PLMD - Periodic Limb Movement Disorder
|
|
|
Who commonly gets RLS Restless Leg Syndrome?
|
19% of pregnant women
|
|
|
Restless leg syndrome and Periodic Limb Movement Disorder is exacerbated by what?
|
caffeine, TCAs, SSRIs, anemia, family history
|
|
|
How do you diagnose Restless leg syndrome and PLMD?
|
RLS- clinically; PLMD- sleep study
|
|
|
What is the FDA approved med for RLS?
|
ropinirole (dopamine agonist)
|
|